| Mrs Priscilla L Fincher, LCSW | |
|
2003 Se Walton Blvd, Bentonville, AR 72712-3725 | |
| (479) 750-2020 | |
| (479) 750-4843 |
| Full Name | Mrs Priscilla L Fincher |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 12 Years |
| Location | 2003 Se Walton Blvd, Bentonville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942528864 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6643-C (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Enhanced Healthcare Nwa Inc | 2163887167 | 3 |
News Archive
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
A new study of sweetened beverages shows that cane sugar and high fructose corn syrup have similar effects on hunger, fullness, and food consumption at lunch.
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
› Verified 6 days ago
| Entity Name | North Arkansas Regenerative Medicine Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356981641 PECOS PAC ID: 3678904034 Enrollment ID: O20200519001488 |
News Archive
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
A new study of sweetened beverages shows that cane sugar and high fructose corn syrup have similar effects on hunger, fullness, and food consumption at lunch.
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
› Verified 6 days ago
| Entity Name | Enhanced Healthcare Nwa Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770284374 PECOS PAC ID: 2163887167 Enrollment ID: O20230426002116 |
News Archive
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
A new study of sweetened beverages shows that cane sugar and high fructose corn syrup have similar effects on hunger, fullness, and food consumption at lunch.
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
› Verified 6 days ago
| Entity Name | Enhanced Healthcare Wound Clinic Nwa Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962104125 PECOS PAC ID: 4688033954 Enrollment ID: O20230705000936 |
News Archive
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
A new study of sweetened beverages shows that cane sugar and high fructose corn syrup have similar effects on hunger, fullness, and food consumption at lunch.
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Priscilla L Fincher, LCSW 2400 S 48th St, Springdale, AR 72762-6683 Ph: (479) 750-2020 | Mrs Priscilla L Fincher, LCSW 2003 Se Walton Blvd, Bentonville, AR 72712-3725 Ph: (479) 750-2020 |
News Archive
One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
Most adults would rather keep talk about colons behind the bathroom door.It's time to talk, says Kim Turgeon, MD, FACP, gastroenterologist in Internal Medicine at the University of Michigan Health System.
A new study of sweetened beverages shows that cane sugar and high fructose corn syrup have similar effects on hunger, fullness, and food consumption at lunch.
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
› Verified 6 days ago
Stephanie Litzinger, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 2508 Se 20th St, Bentonville, AR 72712 Phone: 479-750-2020 Fax: 479-750-4843 | |
Sharon A Odom, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2508 Se 20th St, Bentonville, AR 72712 Phone: 479-273-9088 Fax: 479-750-4843 | |
Keisha Kennedy, PLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 602 N Walton Blvd, Bentonville, AR 72712 Phone: 870-394-4643 Fax: 870-394-4646 | |
Holly Fleming, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 803 Se Plaza Ave Ste 1, Bentonville, AR 72712 Phone: 479-362-5724 | |
Austin Oslica, PLMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2003 Se Walton Blvd, Bentonville, AR 72712 Phone: 479-725-6000 Fax: 479-750-4843 | |
Douglas Spencer Monson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2003 Se Walton Blvd, Suite C, Bentonville, AR 72712 Phone: 479-464-8081 Fax: 479-464-0674 | |
Laura Fox, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2805 Mid Cities Dr Ste 1, Bentonville, AR 72712 Phone: 479-271-7634 Fax: 479-271-7654 |